Beta Drugs
21 November, 2024 14:15 BSE: 531481
NSE: BETAISIN: INE351Y01019
Start SIP in Beta Drugs
Start SIPBeta Drugs Performance
Day Range
52 Week Range
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,983.00
-32 (-1.59%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹1,974.34
- 50 Day
- ₹1,832.68
- 100 Day
- ₹1,673.98
- 200 Day
- ₹1,495.47
- 20 Day
- ₹1,949.00
- 50 Day
- ₹1,827.45
- 100 Day
- ₹1,594.50
- 200 Day
- ₹1,436.64
Beta Drugs Resistance and Support
PIVOT
₹2,012.65
| Resistance | |
|---|---|
| First Resistance | 2,037.30 |
| Second Resistance | 2,059.60 |
| Third Resistance | 2,084.25 |
| RSI | 55.74 |
| MFI | 74.28 |
| MACD Single Line | 82.93 |
| MACD | 76.03 |
| Support | |
|---|---|
| First Support | 1,990.35 |
| Second Support | 1,965.70 |
| Third Supoort | 1,943.40 |
Beta Drugs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 4,700 | 300,001 | 63.83 |
| Week | 4,700 | 320,023 | 68.09 |
| 1 Month | 8,710 | 574,306 | 65.94 |
| 6 Month | 7,439 | 542,392 | 72.91 |
Beta Drugs Result Highlights
Beta Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Beta Drugs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-11-06 | Quarterly Results | |
| 2024-10-19 | To consider Fund Raising | |
| 2024-05-14 | Audited Results | |
| 2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
| 2023-05-08 | Audited Results |